mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.26 |
3e-05 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.23 |
6e-05 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
0.0002 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |